Clinical Trials Browser

Phase 1/2 × donafenib × Head & Neck × Clear all

NCT02698111 2023-05-08

Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma

Phase 1/2 Terminated

Nasopharyngeal Carcinoma